Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ganoderma tsugae ethanol extract is a bioactive preparation derived from the fruiting body of the medicinal mushroom Ganoderma tsugae using an ethanol extraction process. It is rich in triterpenoids such as platycodigenin, cucurbitacin IIb, and ganolecidic acid B[1][5]. Preclinical studies have demonstrated that this extract exhibits hepatoprotective effects by reducing oxidative stress and inflammation in models of liver injury[1][5]. Additionally, it has shown anti-cancer activity against metastatic prostate cancer cells by inhibiting cell proliferation and metastasis through blockade of the PI3K/Akt and MAPK/ERK signaling pathways and induction of caspase-dependent apoptosis[2]. The product is primarily investigated as a functional food or dietary supplement with potential applications for liver protection and adjunctive cancer therapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ganoderma tsugae ethanol extract.